Trial Profile
Safety and efficacy of exenatide in patients with type 2 diabetes using metformin or sulfonylureas and metformin
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 21 Mar 2016
Price :
$35
*
At a glance
- Drugs Exenatide (Primary) ; Metformin; Sulfonylureas
- Indications Type 2 diabetes mellitus
- Focus Registrational; Therapeutic Use
- Sponsors AstraZeneca
- 05 Nov 2007 Status changed from in progress to completed.
- 12 Dec 2006 New trial record.